Search

Long-Acting PrEP: Priority Slides

Slides with the current status and proposed priorities for long-acting PrEP products, regulatory approvals, planning & budgeting, delivery, and much more.

Cabotegravir Implementation

Implementation studies completed, ongoing, or planned for cabotegravir as of October 2025.

Dapivirine Vaginal Ring Implementation

Ongoing and planned implementation studies for the dapivirine vaginal ring as of October 2025.

Cabotegravir Volume

Allocation of non-commercial cabotegravir for PrEP supply in low- and middle-income countries, 2023-2026, as of October 2025.

Dapivirine Vaginal Ring Volume

DVR supply available to low- and middle-income countries as of October 2025.

Cabotegravir Regulatory Approval

Regulatory approvals and those pending for cabotegravir as of October 2025.

Dapivirine Vaginal Ring Regulatory Approval

Regulatory approvals, pending decisions, and appeals as of October 2025.

PrEP Price Comparison

Comparing the annual price of oral TDF/FTC vs. the dapivirine vaginal ring and injectable cabotegravir.

Lenacapavir Regulatory Approval

Regulatory approvals, pending decisions, and appeals as of October 2025.

The Lancet’s Innovations in Sexual & Reproductive Health